1 |
Shin DH, Kim DW, Jeoung YM. 2007. Quality characteristics of bread with added aloe (Aloe vera Linne). Korean J Food and Nutr 20:399-405
과학기술학회마을
|
2 |
Son SM, Park JK. 2004. Study on the classification of health food circulated in the market. J Korean Dietetic Assoc 10:58-64
과학기술학회마을
|
3 |
Stonans I, Stonane E, Russwurm S, Deigner HP, Bohm KJ, Wiederhold M, Jager L, Reinhart K. 1999. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine 11:151-156
DOI
ScienceOn
|
4 |
Jennen DG, Magkoufopoulou C, Ketelslegers HB, van Herwijnen MH, Kleinjans JC, van Delft JH. 2010. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci 115:66-79
DOI
|
5 |
Kanat O, Ozet A, Ataergin S. 2006. Aloe vera-induced acute toxic hepatitis in healthy young man. Eur J Intern Med 17:589
DOI
ScienceOn
|
6 |
Kluge M, Knapp I, Kramer D, Schwerdtner I, Ritter H. 1979. Crassulacean acid metabolism (CAM) in leaves of Aloe arborescens Mill: Comparative studies of the carbon metabolism of chlorenchym and central hydrenchym. Planta 145:357-363
DOI
ScienceOn
|
7 |
Lee HY, Suh SC. 2002. Physicochemical properties of aloe added bagel. Korean J Food and Nutr 15:209-214
과학기술학회마을
|
8 |
Luyendyk JP, Maddox JF, Cosma GN, Ganey PE, Cockerell GL, Roth RA. 2003. Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats. J Pharmacol Exp Ther 307:9-16
DOI
|
9 |
Watkins PB, Seeff LB. 2006. Drug-induced liver injury: Summary of a single topic clinical research conference. Hepatology 43:618-631
DOI
ScienceOn
|
10 |
Westerink WM, Schoonen WG. 2007. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 21:1581-1591
DOI
ScienceOn
|
11 |
Elizondo G, Medina-Diaz IM. 2003. Induction of CYP3A4 by 1alpha,25-dyhydroxyvitamin in HepG2 cells. Life Sci 73:141-149
DOI
|
12 |
Muller SO, Eckert I, Lutz WK, Stopper H. 1996. Genotoxicity of the laxative drug components emodin, aloe- emodin and danthron in mammalian cells: Topoisomerase II mediated?. Mutat Res 371:165-173
DOI
|
13 |
O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, Gao B, Kaludercic N, Angeline A, Bernardi P, Brain P, Hougham C. 2006. High concordance of druginduced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 80:580-604
DOI
|
14 |
Elewa H, Abd-Elmeneem M, Hashem AM, Alshehaby A. 2010. Study of interleukin 8 (IL8) serum level in patients with chronic liver disease due to hepatitis C virus (HCV) with and without hepatocellular carcinoma (HCC). Int J of Hepatol 1:9-17
|
15 |
Gomez-Lechon MJ, Donato T, Ponsoda X, Castell JV. 2003. Human hepatic cell cultures: In vitro and in vivo drug metabolism. Altern Lab Anim 31:257-265
|
16 |
Gomez-Quiroz L, Bucio L, Souza V, Escobar C, Farfan B, Hernandez E, Konigsberg M, Vargas-Vorackova F, Kershenobich D, Gutierrez-Ruiz MC. 2003. Interleukin 8 response and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde or lipopolysaccharide. Hepatol Res 26:134-141
DOI
|
17 |
Grimminger W, Witthohn K. 1993. Analytics of senna drugs with regard to the toxicological discussion of anthranoids. Pharmacology 47:98-109
|
18 |
Grindlay D, Reynolds T. 1986. The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol 16:117-151
DOI
ScienceOn
|
19 |
Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, Tacke F. 2011. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 6:e21381
DOI
|
20 |
Yang HN, Kim DJ, Kim YM, Kim BH, Sohn KM, Choi MJ, Choi YH. 2010. Aloe-induced toxic hepatitis. J Korean Med Sci 25:492-495
DOI
ScienceOn
|
21 |
National Institute of Food and Drug Safety Evaluation. 2011. Collection and Safety Management of the Adverse Events for Health/Functional Foods. pp. 15
|
22 |
Ministry of Food and Drug Safety. 2014. Health Functional Foods. Available from http:// www.foodnara.go.kr/hfoodi/ [cited 2014 April 30]
|
23 |
Park CS, Shin YS, Ryu IW, Lee KS. 2000. Antimicrobial activity of extracts from Aloe vera peel against Streptococcus mutans JC-2(I). Korean J Food and Nutr 13:139-145
과학기술학회마을
|
24 |
Rabe C, Musch A, Schirmacher P, Kruis W, Hoffmann R. 2005. Acute hepatitis induced by an Aloe vera preparation: A case report. World J Gastroenterol 11:303-304
DOI
|
25 |
Reynolds T, Dweek AC. 1999. Aloe vera leaf gel: A review update. J Ethnopharmacol 68:3-37
DOI
ScienceOn
|
26 |
Reynolds T. 2005. Hemlock alkaloids from Socrates to poison aloes. Phytochemistry 66:1399-1406
DOI
|
27 |
Russwurm S. Stonans I, Stonane E, Weigand G, Wiederhold M, Jager L, Reinhart K. 1998. HepG2 hepatocytes express IFN- , M-CSF, oncostatin-M, ICAM-1, IL-4, IL-5, IL-7, IL-10, IL-11, IL-12 and IL-6 receptor genes in vitro. Crit Care 2:P005
|
28 |
Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K. 1994. Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease. J Hepatol 21:527-535
DOI
|
29 |
Gutierrez-Ruiz MC, Gomez Quiroz LE, Hernandez E, Bucio L, Souza V, Llorente L, Kershenobich D. 2001. Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. Isr Med Assoc J 3:131-136
|
30 |
Huang YS, Hwang SJ, Chan CY, Wu JC, Chao Y, Chang FY, Lee SD. 1999. Serum levels of cytokines in hepatitis Crelated liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi 62:327-333
|
31 |
Bottenberg MM, Wall GC, Harvey RL, Habib S. 2007. Oral Aloe vera-induced hepatitis. Ann Pharmacother 41:1740-1743
DOI
ScienceOn
|
32 |
Brusick D, Mengs U. 1997. Assessment of the genotoxic risk from laxative senna products. Environ Mol Mutagen 29:1-9
DOI
|
33 |
Curciarello J, De Ortuzar A, Borzi S, Bosia D. 2008. Severe acute hepatitis associated with intake of Aloe vera tea. Gastroenterol Hepatol 31:436-438
DOI
|
34 |
Skett P, Tyson C, Guillouzo A, Maier P. 1995. Report on the international workshop on the use of human in vitro liver preparations to study drug metabolism in drug development. Biochem Pharmacol 50:280-285
DOI
|
35 |
Olsavsky KM, Page JL, Johnson MC, Zarbl H, Strom SC, Omiecinski CJ. 2007. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol 222:42-56
DOI
|
36 |
Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. 2004. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmaco 199:193-209
DOI
|